NSC 31150

CAS No. 51244-45-2

NSC 31150( —— )

Catalog No. M33810 CAS No. 51244-45-2

NSC 31150 is a potential PPAR agonist with antibacterial, antidiabetic and antioxidant activities and may be used to study cancer and bacterial infections.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 411 In Stock
10MG 562 In Stock
25MG 866 In Stock
50MG 1097 In Stock
100MG 1469 In Stock
200MG 2009 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NSC 31150
  • Note
    Research use only, not for human use.
  • Brief Description
    NSC 31150 is a potential PPAR agonist with antibacterial, antidiabetic and antioxidant activities and may be used to study cancer and bacterial infections.
  • Description
    NSC 31150 is a potential PPAR agonist with antibacterial, antidiabetic and antioxidant activities and may be used to study cancer and bacterial infections.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Antioxidant
  • Recptor
    Antioxidant | PPAR | Antibiotic
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    51244-45-2
  • Formula Weight
    274.12
  • Molecular Formula
    C10H5Cl2NO2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1SC(=CC2=CC=C(Cl)C=C2Cl)C(=O)N1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Isoquercitrin

    Isoquercitrin is a potential stimulator of bone mineralization used for prophylaxis of osteoporotic disorders.

  • BHT FCC NF

    BHT is also used as an antioxidant additive in such diverse products as cosmetics, pharmaceuticals, rubber, electrical transformer oil.

  • Nrf2 activator-3

    Nrf2 activator-3 is a potent Nrf2 activator with potential anti-inflammatory, antioxidant, and anti-tumor activities, suitable for studying neurological and immune-related diseases.